These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20377905)

  • 1. Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.
    Nickman NA; Haak SW; Kim J
    BMC Nurs; 2010 Apr; 9():6. PubMed ID: 20377905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis.
    Pollock RF; Qian Y; Wisniewski T; Seitz L; Kappelgaard AM
    Med Devices (Auckl); 2013; 6():107-14. PubMed ID: 23946672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.
    Tauber M; Jaquet D; Jesuran-Perelroizen M; Petrus M; Bertrand AM; Coutant R;
    Patient Prefer Adherence; 2013; 7():455-62. PubMed ID: 23737664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.
    Kappelgaard AM; Hansen NÅ
    Expert Rev Med Devices; 2013 May; 10(3):321-7. PubMed ID: 23560872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
    Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
    Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.
    Yuen KC; Amin R
    Patient Prefer Adherence; 2011 Mar; 5():117-24. PubMed ID: 21448295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-use versus reusable medical devices in spinal fusion surgery: a hospital micro-costing analysis.
    Bouthors C; Nguyen J; Durand L; Dubory A; Raspaud S; Court C
    Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1631-1637. PubMed ID: 31350650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
    Pawlikowska-Haddal A
    Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.
    Rohrer TR; Winter F; Qvist M; Kappelgaard AM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1603-12. PubMed ID: 24073645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of dose selection attributes with audible notification in insulin pen devices.
    Asakura T; Seino H
    Diabetes Technol Ther; 2005 Aug; 7(4):620-6. PubMed ID: 16120036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient acceptability of a new 3.0 ml pre-filled insulin pen.
    D'Eliseo P; Blaauw J; Milicević Z; Wyatt J; Ignaut DA; Malone JK
    Curr Med Res Opin; 2000; 16(2):125-33. PubMed ID: 10893656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The best insulin injection pen device for caregivers: results of injection trials using five insulin injection devices.
    Yakushiji F; Fujita H; Terayama Y; Yasuda M; Nagasawa K; Shimojo M; Taniguchi K; Fujiki K; Tomiyama J; Kinoshita H
    Diabetes Technol Ther; 2010 Feb; 12(2):143-8. PubMed ID: 20105044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey.
    Adachi M
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1105-10. PubMed ID: 23843576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Force requirements and insulin delivery profiles of four injection devices.
    Toraishi K; Yuizono Y; Nakamura N; Kato S; Aoki T; Ashida K; Sako Y
    Diabetes Technol Ther; 2005 Aug; 7(4):629-35. PubMed ID: 16120038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.